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Abstract 
Objective: The factors underlying the aetiology of fibromyalgia (FM) are largely unknown. 
According to the generalized hypervigilance hypothesis (GHH), FM patients show excessive 
attention towards pain stimuli and other sensory events, thereby increasing pain perception 
and dysfunctional behaviour. We tested this notion by assessing interoceptive accuracy (IA) 
in FM patients and matched healthy controls. We also tested the hypothesis that FM is 
characterized by reduced self-regulatory capacity as indexed by heart rate variability (HRV). 
Methods: 47 FM patients (Mage = 45.5, 39 females) and 45 healthy controls (Mage = 44.9, 37 
females) completed several self-report scales (Body Vigilance Scale, Depression Anxiety 
Stress Scales, Pain Catastrophizing Scale). To derive HRV, heart rate was monitored under 
resting conditions; for the assessment of IA participants performed a heartbeat tracking task in 
which they were asked to silently count their heartbeats. Results: FM patients reported higher 
body vigilance than healthy controls, but there were no group differences in IA. FM patients 
had lower HRV compared with healthy controls. HRV did not predictor IA. Conclusion: In 
conclusion, our findings do not support the hypothesis of generalized hypervigilance in FM 
patients. Patients reported a heightened focus on bodily sensations, which was not reflected in 
IA. It may be that hypervigilance is not a general and stable characteristic but is rather context 
dependent and modality-specific.  
 
Key words: generalized hypervigilance, fibromyalgia, interoceptive accuracy, heart rate 
variability 
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1. Introduction 
Fibromyalgia (FM) is characterized by widespread musculoskeletal pain, and is 
accompanied by fatigue, sleep disorders, memory problems and mood disturbances (1). 
Despite its prevalence and increasing research, the factors underlying the aetiology of FM 
remain elusive. One potentially important aetiological factor is generalized hypervigilance, 
i.e. the excessive attention towards potential threat. The generalized hypervigilance 
hypothesis (GHH) posits that patients with medically unexplained symptoms, such as FM, 
focus their attention on potential threat signals, resulting in increased pain sensitivity, and the 
amplified perception of non-painful sensations in other sensory modalities (2,3). McDermid 
and colleagues (2) postulated a perceptual style of amplification extending beyond the pain 
domain. In line with this assumption, subsequent studies aimed to investigate the GHH with 
innocuous stimuli (e.g. 4, 41). Other studies, however, interpreted the GHH as referring to 
aversive stimuli only (e.g. 3). The purpose of the current study was to investigate whether 
generalized hypervigilance also occurs in regard of non-threatening internal bodily signals.   
Despite its importance for a better understanding of hypervigilance in FM, research on 
the perception of internal signals in FM patients, i.e. interoception, is scarce. So far, 
generalized hypervigilance has been supported by (a) self-report measures, on which FM 
patients typically show elevated scores for vigilance to pain (4–6) and (b) experimental 
measures showing decreased pain thresholds and tolerance levels for experimentally induced 
pain (2,7,8) innocuous (e.g. auditory) stimuli (3,9) and (c) perceptual amplification of non-
aversive interoceptive stimulation (10) in FM patients. In line with these findings, FM patients 
are expected to be hypervigilant towards internal signals and, thus, more accurate in 
perceiving internal bodily signals. 
The accuracy of perceiving internal bodily changes has been conceptualised as a trait 
(11,12), with the process of accurately detecting and tracking bodily signals relying on actual 
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bodily changes. The assessment of interoceptive accuracy (IA), therefore, requires the 
monitoring of physical changes, which can be readily measured. The heartbeat tracking task is 
a useful assessment paradigm, as heartbeats are easily quantifiable as discrete and 
determinable stimuli (13–15). Numerous studies have used this paradigm to assess IA in panic 
patients in order to investigate hypervigilance towards bodily sensations (16–20).  
In addition, FM may also be characterized by a deficiency in inhibiting irrelevant 
information or prioritizing attention towards relevant stimuli or sensations (21). According to 
the Neurovisceral Integration Model (22,23), insufficient inhibitory control can be 
physiologically indexed by vagally mediated heart rate variability (HRV). Heart rate reflects 
the combined result of sympathetic and parasympathetic activity at the sino-atrial node (24). 
Beat-to-beat variability indexes activity in this reciprocal inhibitory cortico-subcortical neural 
circuit, and serves as the structural link between psychological processes and health-related 
physiological processes. As HRV reflects activity that is dynamically organized in response to 
environmental challenges, it allows for the quantification of behavioural flexibility and 
adaptability in a changing environment, i.e. self-regulatory capacity. In line with this 
reasoning, previous research has found lower HRV in FM patients compared to healthy 
controls (25,26). Porges (1992) defines the ability to rapidly shift and effectively sustain 
attention in accord with situational demands as one critical component of self-regulation (27). 
Accordingly, lower HRV has been found to predict hypervigilance and inefficiency of 
attentional regulation (28).  
The aims of the current study were threefold: (1) to investigate IA in FM patients, (2) 
to replicate previous findings on lower HRV in FM patients compared to healthy controls, and 
(3) to examine the predictive value of self-regulatory capacity for IA. We, therefore, assessed 
HRV and performance in a heartbeat tracking task (29) in a group of FM patients, compared 
to age- and sex-matched healthy controls. We hypothesized that 1) FM patients are more 
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accurate in counting their heartbeats, 2) HRV, as an index of self-regulatory capacity, is 
reduced in FM patients and 3) HRV is negatively associated with IA.  
 
2. Methods 
2.1. Participants and procedure 
Participants between the age of 18 and 65 years were recruited in the context of a larger 
project (see protocol ASEF-I; http://hdl.handle.net/1854/LU-5686902) between January 2014 
and March 2014. Individuals were eligible to participate if they either were diagnosed with 
FM and fulfilled the ACR-90 criteria for FM (FM group) or did not report a current pain 
problem (healthy control group). Additional inclusion criteria were: (1) sufficient knowledge 
of the Dutch language; (2) absence of neurological conditions. Furthermore, individuals were 
excluded when they were unable to use both index fingers, reported abnormal sensations in 
the arms or if their eyesight was not normal or not corrected-to-normal (e.g., by glasses). The 
latter three criteria were exclusion criteria in regard of a task, which was not part of this study 
(see ASEF-I). FM patients were recruited via the Multidisciplinary Pain Clinic of Ghent 
University Hospital. They were informed about the study with a poster in the waiting room of 
the hospital. Patients who were interested in taking part left their contact details and were 
screened for eligibility. Individuals of the control group were recruited using advertisements 
in a local newspaper, flyers and the university website. Individuals who volunteered were 
contacted and screened for eligibility. Both groups were matched at group level for age, sex 
and educational level. A total of 98 individuals took part in the study: 49 FM patients and 49 
healthy controls.  
As the study was part of an extended protocol, we only report the procedure relevant 
for the current research question. In a first step, participants filled out a set of standardised 
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questionnaires, including the Body Vigilance Scale (BVS; Schmidt, Lerew, & Trakowski, 
1997), the Depression Anxiety Stress Scales (DASS; Lovibond & Lovibond, 1995) and the 
Pain Catastrophizing Scale (PCS; Sullivan, Bishop, & Pivik, 1995) via an online assessment 
system (LimeSurvey) at home (if this was not possible, participants received a paper version 
to fill in). In a second step, i.e., when arriving at the research lab, participants rated their 
current pain and indicated whether they had consumed coffee within the last two hours 
(exclusion criterion). The experimenter then checked the ACR-criteria (1) with the patient to 
confirm the FM diagnosis. Next, heart rate was measured over a period of five minutes. 
Finally, the participant performed a heartbeat tracking task (29). The study design was 
approved by the Ethics Review Panel of the University of Luxembourg and the Medical 
Ethics Committee, University Hospital Ghent. Participants gave written informed consent and 
received a token of gratitude of 35€ for their participation. 
 
2.2. Self-report data 
Pain intensity at the moment of testing was assessed using the item “how intense is 
your pain now?”. Participants answered by using a visual analogue scale from 0 (“no pain”) 
to 100 (“worst imaginable pain”).  
Depressive mood, anxiety and stress were assessed with the DASS (31). Each of the 
subscales contain 14 items in which participants are asked to rate the extent to which they 
have experienced each state (e.g. “I found it difficult to relax”, “I felt sad and depressed”) 
over the past week using a 4-point Likert scale (0 = did not apply to me at all to 3 = applied to 
me very much, or most of the time). Scores may range from 0 to 42. Within the current 
sample, the scales were found to have excellent internal consistencies (α = .97 for depression, 
α = .92 for anxiety and α = .95 for stress).   
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Catastrophic thinking about pain was assessed with the PCS (32). The scale consists 
of 13 items in which participants indicate the degree to which they experienced catastrophic 
thoughts or feelings during pain episodes (e.g. “I keep thinking about how much it hurts”, “I 
can’t seem to keep it out of my mind”) on a 5-point Likert scale (0 = not at all to 4 = all the 
time). Scores may range from 0 to 52. This scale showed a good reliability and validity in 
healthy populations and chronic pain patients (33). Cronbach’s alpha for the current study was 
.95. 
Vigilance for bodily sensations was assessed using the BVS (30). The BVS assesses 
attentional focus for bodily sensations and consists of four items in which participants indicate 
on an 11-point Likert scale (0 = none to 10 = extreme) the degree to which they agree with a 
particular statement regarding selective attention to bodily sensations. Scores on item 3 (“On 
average, how much time do you spend each day ‘scanning’ your body for sensations [e.g. 
sweating, heart palpitation, dizziness]”) are divided by 10. The last item involves having 
participants rate their attention to 15 bodily sensations (e.g. heart palpitations). Responses to 
the fourth item are averaged to yield a single score. Summing the four items derives a total 
score of the BVS with a range from 0 to 40. The questionnaire has adequate internal 
consistency in clinical and nonclinical populations (30,34). Cronbach’s alpha for the current 
study was acceptable (α = .70).  
 
2.3. Heart rate variability (HRV) 
During the baseline period, participants sat in individual cubicles and were instructed 
to sit quietly and relax. Inter-beat intervals were assessed based on electrocardiographic 
recordings for 5 minutes at a sampling rate of 1000 Hz using a Polar watch RS800CX (Polar 
Electro Oy, Kempele, Finland).  
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2. 4. Perception of bodily sensations  
IA was assessed with a heartbeat tracking task based on the paradigm first introduced 
by Schandry (29). The actual number of heartbeats was recorded with the same Polar watch 
used for baseline recordings and analysed via Polar ProTrainer software. Participants were 
asked to silently count all the heartbeats they perceived in their body without taking their 
pulse or attempting any other manipulation to facilitate the discrimination of their heartbeats. 
Instructions were given via an E-Prime-based script on a written screen to minimize bias 
introduced by the experimenter. The task consisted of four intervals of 25, 35, 45 and 55 
seconds in randomized order and the duration of these intervals was unknown to participants. 
The intervals were separated by standard resting periods of 30 seconds. A visual countdown 
of 3-2-1 followed by a cross on the screen indicated the beginning of the counting period. The 
period ended with the disappearance of the cross. After the counting period, participants were 
asked to indicate the number of counted heartbeats. The number of counted heartbeats was 
compared to the recorded number of heartbeats. Participants started with one training interval 
of 25 seconds. IA was calculated as the mean score across all the counting intervals (with n = 
number of valid counting intervals) using the formula IASchandry = 1 𝑛⁄ ∑[1 −
(∣ 𝐻𝐵𝑟𝑒𝑐𝑜𝑟𝑑𝑒𝑑 −  𝐻𝐵𝑐𝑜𝑢𝑛𝑡𝑒𝑑 ∣) 𝐻𝐵𝑟𝑒𝑐𝑜𝑟𝑑𝑒𝑑⁄ ]. Scores vary between 0 and 1 with a maximum 
score of 1 indicating absolute accuracy. Furthermore, as Brown and colleagues (35) have 
shown that physical symptom reporting is related to the tendency to report false alarms in a 
somatosensory signal detection task, we additionally calculated a simple IA score to 
distinguish over- from underreporting using the formula IAsimple = 1 𝑛⁄ ∑(𝐻𝐵𝑐𝑜𝑢𝑛𝑡𝑒𝑑 −
 𝐻𝐵𝑟𝑒𝑐𝑜𝑟𝑑𝑒𝑑 )/𝐻𝐵𝑟𝑒𝑐𝑜𝑟𝑑𝑒𝑑 with a positive score reflecting overreporting and a negative score 
reflecting underreporting of heart beats.  
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2.5. Data handling and reduction 
To calculate HRV-indices, sequential interbeat intervals were downloaded using the 
software Polar Pro Trainer 5. All signals were visually inspected for artefacts. HRV analysis 
was performed using the software ARTiiFACT (36). First, measurement artefacts were 
identified by applying a distribution-related threshold criterion. Erroneous beats were deleted 
and substituted by cubic spline interpolation of neighbouring intervals. Time domain 
measures were directly calculated from RR-interval series. Spectral analysis of the RR-
interval series was carried out using Fast Fourier Transformation. Following the 
recommendations of the Task Force of the European Society of Cardiology and the North 
American Society of Pacing and Electrophysiology (1996) we defined the high frequency 
band (HF) as 0.14 to 0.4 Hz and used the following time and frequency HRV parameters for 
statistical analyses: root mean square of successive differences (RMSSD), percent of 
difference between adjacent RR intervals that are greater than 50 ms (pNN50) and the 
absolute power in the HF band (HFabs) (37). We focused on those parameters because they 
reflect parasympathetic control over heart rate (37). The criterion for outliers in HRV 
measures was defined as values more than 3 SD above the sample mean (cf. 36). After 
correcting for outliers, HFabs was log transformed to adjust for skewness of the distribution 
(lnHFabs). Regarding the heartbeat tracking task, for 9 out of 89 participants (5 FM, 4 
controls) only three valid intervals were included due to recording problems.  
Four participants (1 FM, 3 controls) were excluded from the final analyses due to 
equipment failure. Furthermore, two participants (1 FM, 1 control) were excluded because of 
outliers in HRV. Both participants scored more than three SD above the sample mean. The 
final sample, therefore, consisted of 47 FM patients and 45 healthy controls.  
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2.6. Statistical analyses 
Differences in characteristics between the FM and healthy control groups were 
examined using independent samples t-tests. Pearson correlations were performed between 
IA, HRV-indices and self-report measures. According to hypothesis one, we expected that FM 
patients are more accurate in counting their heartbeats than healthy controls. This was tested 
using an independent samples t-test (2-tailed). Effect size indices for independent samples 
(Cohen’s d) and the 95% confidence interval (95% CI) were calculated (39,40). Hypothesis 
two states that HRV is reduced in FM patients. To test this hypothesis, a multivariate analysis 
of variance (MANOVA) was conducted in regard of the three related HRV-indices. Finally, 
we tested the hypothesis of a negative relationship between HRV and IASchandry using a 
hierarchical linear regression analysis. In a first step, we entered HRV as predictor. In a next 
step, we aimed at controlling whether the relationship remains present when controlling for 
group. For this analysis, we choose HRV-RMSSD because of its robust statistical properties 
(cf. 35). Critical alpha level for all analyses was set to .05. 
 
3. Results 
3.1. Descriptive statistics 
Table 1 summarizes sample characteristics and self-report data. There were no 
significant differences in age, gender or educational level (all p’s > .244). All of the FM 
patients, and 26.7% of the healthy controls reported pain at the moment of testing. Pain 
intensity at the moment of testing was significantly higher in the FM than in the healthy 
control group. Pain intensity scores in the FM group ranged between 8 and 84, compared to 0 
and 17 in the control group. FM patients had significantly higher scores on all self-report 
measures as compared to healthy controls (see table 1).  
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Table 1 
Descriptive Statistics by Participant Group 
Variable Group 
Difference test 
 
FM  
(n = 47) 
Control 
(n = 45) 
Age (M, SD) 45.5 (9.2) 44.9 (12.2) t(82)a = .26, p = .792, d = 0.06 
Gender (n women) 39 37 χ2(1) = .009, p = .924, w = 0.00 
Educational level   χ2(2) = 2.82, p = .244, w = 0.29 
    College/University  38.3% 55.6%  
    Secondary school 57.4% 42.2%  
    Primary school 4.3% 2.2%  
Pain intensity at moment of 
testing (M, SD) 
43.87 (21.5) 1.60 (3.8) t(49)a = 13.28, p < .001, d = 2.73 
DASS – Depression (M, SD) 13.2 (10.6) 5.84 (6.4) t(75)a = 3.95, p < .001, d = 0.84 
DASS – Anxiety (M, SD) 11.34 (7.6) 2.89 (3.6) t(66)a = 6.91, p < .001, d = 1.42 
DASS – Stress (M, SD) 15.26 (7.8) 8.11 (7.4) t(90) = 4.51, p < .001, d = 0.94 
PCS (M, SD) 21.62 (10.8) 9.64 (9.6) t(90) = 5.61, p < .001 , d = 1.17 
BVS (M, SD)  18.41 (6.6) 14.05 (6.4) t(90) = 3.21, p = .002, d = 0.67 
 
Note. FM = fibromyalgia; DASS = Depression Anxiety Stress Scales; PCS = Pain 
Catastrophizing Scale; BVS = Body Vigilance Scale. a = equal variances not assumed. 
 
 
 
There were no significant associations between IA and any other measure (-.081 < r > 
.142, ns). Body vigilance was related to higher pain intensity at the moment of testing as well 
as to higher scores in depression, anxiety, stress and pain catastrophizing. Further, we found a 
significant negative correlation (r = -.223, p < .05) between pain catastrophizing and pNN50. 
HRV-indices were highly interrelated. Table 2 gives an overview of means and correlations.   
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Table 2 
Means (M), Standard Deviations (SD) and Pearson Correlation Coefficients for All Measures 
 M SD 2 3 4 5 6 7 8 9 10 11 
1. IASchandry 0.56 0.24 .548
*** .117 -.005 .024 .110 .051 -.081 .142 .112 .102 
2. IAsimple -0.38 0.35  .075 -.054 .068 .003 .003 .080 .054 .040 .018 
3. Pain intensity at moment 
of testing 
23.20 26.30   .424*** .590*** .401*** .554*** .299** -.232* -.193† -.147 
4. Depression (DASS) 9.59 9.67    .685*** .676*** .639*** .373*** -.114 -.112 -.125 
5. Anxiety (DASS) 7.21 7.28     .715*** .642*** .527*** -.099 -.069 -.064 
6. Stress (DASS) 11.76 8.36      .575*** .436*** -.071 -.075 -.085 
7. Pain Catastrophizing     
   (PCS) 
15.76 11.82       .450*** -.182† -.223* -.098 
8. Body Vigilance (BVS) 16.28 6.83        -.071 -.049 -.021 
9. RMSSD 22.60 12.89         .935*** .868*** 
10. pNN50 6.20 9.37          .876*** 
11. lnHFabs 4.98 1.24           
 
Note. IA = interoceptive accuracy; DASS = Depression Anxiety Stress Scales; PCS = Pain Catastrophizing Scale; BVS = Body Vigilance Scale; RMSSD = 
root mean square of successive differences; pNN50 = percent of difference between adjacent RR intervals that are greater than 50 ms; lnHFabs = 
log transformed absolute power in the HF band. † p < .10; * p < .05; ** p < .01; *** p < .001.  
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3.2. Interoceptive accuracy  
IASchandry did not differ between the FM group (M = 0.59; SD = 0.25) and the healthy 
control group [M = 0.52; SD = 0.24, t(90) = 1.28, p = .205, d = 0.29, 95% CI -0.04 to 0.17]. 
Similarly, additional analyses using the formula to detect false alarms (IAsimple), did not show 
differences between the FM (M = -0.33; SD = 0.34) and the healthy control group [M = -0.42; 
SD = 0.35, t(90) = 1.26, p = .212, d = 0.26, 95% CI -0.05 to 0.23]. 
 
3.3. Heart rate variability 
Using Pillai’s trace, we found a significant effect for group in all HRV-indices, V = 
0.09, F(3,88) = 2.94, p = .037. Follow-up tests revealed lower RMSSD and pNN50 in FM 
patients compared with healthy controls. Results of separate univariate ANOVAs are 
summarized in Table 3. 
 
Table 3 
Heart Rate Variability Measures by Participant Group 
HRV-indices 
Group 
Difference test (ANOVAs) FM (n = 47) 
(M, SD) 
Control (n = 45) 
(M, SD) 
RMSSD  19.36 (10.6) 25.98 (14.3) F(1,90) = 6.41, p = .013, η2 = .07 
pNN50 4.13 (6.9) 8.36 (11.1) F(1,90) = 4.88, p = .030, η 2 = .05 
lnHFabs    4.77 (1.2) 5.19 (1.2) F(1,90) = 2.58, p = .112, η 2 = .03 
 
Note. HRV = heart rate variability; FM = fibromyalgia; RMSSD = root mean square of 
successive differences; pNN50 = percent of difference between adjacent RR intervals that are 
greater than 50 ms; lnHFabs = log transformed absolute power in the HF band. 
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3.4. Association between interoceptive accuracy and heart rate variability 
We investigated the predictive value of HRV for IASchandry using a hierarchical 
regression analysis. The regression analysis indicated that HRV did not explain a significant 
amount of the variance in IASchandry when entered as a single predictor [F(1,90) = 1.86, p = 
.176, R2 = .02], with β = .142. When controlling for group as a predictor, the regression model 
was not significant [F(2,89) = 2.41, p = .096, ΔR2 = .03]. This model is presented in table 4.  
 
Table 4 
Hierarchical Regression Model Explaining Interoceptive Accuracy, with Standard Errors 
and 95% Confidence Intervals Reported in Parentheses 
 b SE B β p 
Step 1     
HRV (RMSSD) 0.003 (-.001, .007) 0.002 .142 .176 
Step 2     
HRV (RMSSD) 0.004 (0.000, 0.008) 0.002 .189 .080 
Group -0.088 (-0.191, 0.015) 0.052 -.182 .092 
 
Note. R2 = .020 for step 1; ΔR2 = .031 for step 2; RMSSD = root mean of square of successive 
differences; HRV = heart rate variability.  
 
4. Discussion 
The aims of the current study were (1) to assess the accuracy of perceiving 
interoceptive signals in FM patients using a heartbeat tracking task, (2) to compare HRV 
between groups, and (3) to investigate the predictive value of HRV for IASchandry. Firstly, FM 
patients did not differ from healthy controls in IA. Secondly, FM patients showed decreased 
HRV compared to healthy controls. Thirdly, HRV did not predict IASchandry.  
Contrary to our expectations, we did not find altered perception of interoceptive 
signals in FM patients, as assessed with the heartbeat tracking task, neither using the 
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traditional formula by Schandry (29), nor the additional formula (IAsimple) aiming at the 
detection of false alarms. Although the small CI indicates robustness of the finding that the 
accuracy of detecting heart beats does not differ between FM patients and healthy controls, it 
is opposed to previous results showing increased pain sensitivity and amplified perception of 
painful and non-painful stimuli in FM patients (2,3,7–9). The present finding, however, is in 
line with a number of studies, which failed to demonstrate prioritization of external innocuous 
stimuli in FM patients (4,41). In the study by Van Damme and colleagues (41), participants 
performed a tactile change detection task in which they had to detect whether there was a 
change between two consecutively presented patterns of tactile stimuli presented to various 
body locations. Neither in the unpredictable condition nor when changes occurred at 
unexpected locations in the predictable condition, FM patients showed better tactile change 
detection than healthy controls. Peters and colleagues (4) used a reaction time paradigm in 
which participants had to respond as fast as possible to innocuous electrical stimuli which 
were gradually increasing in strength and administered to one of four different body locations. 
This task was presented under single and dual (with a second visual reaction time task) task 
conditions. FM patients did not show superior detection of weak electrical stimuli either under 
single or dual task conditions.  
In regard of the different accounts of the GHH, the current findings do not support the 
hypothesis that FM patients have a perceptual style of amplification, suggested by McDermid 
and colleagues (2). Current findings do, however, not rule out the interpretation of Hollins and 
colleagues (3), which states that generalized hypervigilance only relates to unpleasant stimuli. 
If, however, only stimuli that are appraised as unpleasant lead to hypervigilance, we might 
expect that this mechanism is highly contextual and specific. Accordingly, the current results 
cast doubt on the view of hypervigilance as a general characteristic, which applies to all kinds 
of signals equally. Rather, hypervigilance may be a dynamic process, which is associated with 
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specific conditions or modalities, that occurs when the fear system is activated and an 
individual is concerned about pain (42–45). Hypervigilance would then be expected to only 
appear in the context of pain or threat, and this has even been shown for healthy individuals 
who respond with a stronger focus on body parts where pain or bodily threat was anticipated 
(46–49). Heartbeats are not threatening or aversive for FM patients per se, and the 
experimental setting did not suggest bodily threat, explaining the current lack of group 
differences in IA. This may further explain why higher IA has been found in panic pain 
patients compared to healthy controls (16,17,50), as heartbeats definitely constitute 
threatening bodily sensations for these patients. Further, the fact that IA and scores on the 
BVS (30) were not associated, might point to modality-specific hypervigilance. Future studies 
should investigate hypervigilance in different pain-related and threatening contexts as well as 
in regard to different modalities in FM patients to better understand the role of interoception 
on the aetiology of FM. 
Interoception entails a complex process with different aspects (51–54). For example, 
IA can be conceptualized as a function of sensitivity and specificity (52). According to the 
assumption of a perceptual style of amplification in FM patients (2), one may have expected a 
superior detection of bodily signals for FM patients. However, it may be reasonable to assume 
that not only the bodily signal, but also the noise, may be amplified (35), impeding the 
accuracy of the detection of heart beats. FM patients may then indeed be more sensitive to 
interoceptive signal change, similarly as to exteroceptive stimuli (2,3,7,8), but not able to 
reject competing signals as proposed by Pennebaker’s competition-of-cues model (55). This 
model posits that only a limited amount of information can be processed at a given moment in 
time. In case of FM, persistent pain would then interfere with the processing of other bodily 
sensations, result in diminished IA and indicate the absence of generalized hypervigilance. In 
line with this reasoning are findings showing that individuals who report somatosensory 
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amplification are less accurate in counting their heartbeats (56). Likewise, one recent study 
reported lower IA in FM patients than in healthy controls, using the same behavioural 
paradigm for the assessment of IA (57). Several methodological differences between Duschek 
et al.’s (57) and the current study may, however, explain the diverging results. For example, 
the instructions for the heartbeat tracking task in the current study were standardized and 
presented on a screen, whereas in Duschek et al. (57) they were signalled by the experimenter, 
with the latter representing a potential source of bias. In addition, our findings are based on 
four compared to only three counting periods used in the study by Duschek and colleagues 
(57). The number of counting periods may affect the reliability of the task, but further 
research is necessary to provide specific evidence on this topic. Furthermore, and in contrast 
to Duschek et al.’s study (57), the current study included balanced sample sizes and groups 
matched for age, sex and educational level.  
Interestingly, results of the heartbeat tracking task contrasted with self-reported 
hypervigilance, i.e. the tendency to focus on bodily sensations. Scores on the BVS (30) were 
significantly higher in FM patients, a result which is in line with previous findings (4,5,58). It 
is, however, important to note that self-reported body vigilance may be partly affected by the 
experience of persistent pain. Self-report measures might be biased by non-attentional factors 
and higher scores might reflect somatic complaints rather than excessive attention (59).  
Groups differed in HRV in that FM patients showed lower HRV, specifically in the 
more robust time domain measures of HRV. These findings are in line with previous research 
comparing HRV between FM patients and healthy controls (25,26). Chronic pain conditions 
are accompanied by cognitive, emotional and physiological disturbances (1). The adaptation 
to these conditions requires the capacity to control one’s cognition, emotion and behaviour, 
i.e. self-regulatory capacity (60,61). The persistent challenge posed by chronic pain may 
exhaust patients’ self-regulatory resources (62), which may be reflected in lower HRV. We 
18 
 
further expected reduced HRV to be related to increased hypervigilance (21), as a link 
between resting cardiac vagal tone and attentional control has been previously reported (27). 
Reduced HRV, associated with increased hypervigilance, would then predict more accurate 
perception of interoceptive signals. We could not confirm this hypothesis. We do, however, 
find a non-significant trend towards a positive association between HRV and IA with a small 
effect size. A positive relationship between the perception of internal bodily states and the 
strength of controlling one’s behaviour might indeed be expected based on Damasio’s somatic 
marker hypothesis (63–65). This theory proposes that somatic states mark response options 
which guide our behaviour. More precisely, internal and external stimuli elicit somatic states 
which involve physiological modifications and are processed in specific brain structures (e.g. 
amygdala, ventromedial prefrontal cortex). These patterns of body-related responses to 
stimuli, i.e. emotions, provide an individual with options to respond to a stimulus and guide 
his behaviour. Some studies have emphasized the role of feedback of bodily signals in 
behavioural processes by linking higher IA to increased self-reported self-regulatory capacity 
or self-regulation of physical load (66,67).  
Further research is important to elaborate on body perception in FM patients and 
investigate hypervigilance with different experimental paradigms and in different contexts. As 
research regarding the perception of internal bodily sensations is scarce, future studies may 
aim at expanding this research. One may think of investigating cardiac interoception also by 
other paradigms, such as the signal discrimination method in which the participant is cued to 
judge whether a series of external stimuli are presented simultaneously or delayed relative to 
one’s own heart beat (68,69). One may also further investigate the role of the threat value for 
hypervigilance towards bodily sensations in an experimentally manipulated stress-related 
context. As such, interoceptive threat may be evoked by hyperventilation due to CO2 
inhalation. Also the direction of any association between the perception of interoceptive 
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signals and self-regulatory processes remains unclear. Future studies could expand the 
assessment of self-regulatory capacity by including self-report measures and experimental 
self-regulation tasks such as an exposure to temptation or an anagram task (62,70).  
Some limitations must be pointed out. Firstly, one may argue that IA is not a suitable 
concept, and, therefore, the heartbeat tracking task not be an appropriate operationalization for 
investigating generalized hypervigilance. While generalized hypervigilance is supposed to 
lead to amplified perception of all sensations, it is debatable whether it would imperatively 
lead to more accurate perception. Secondly, we did not assess body mass index (BMI) which 
has been related to reduced IA (71), so that we cannot rule out for IA results to have been 
systematically affected by differences in BMI. Thirdly, the present study used a cross-
sectional design, which does not allow for conclusions on cause-effect relationships. Fourthly, 
pain medication may have affected the results. Finally, in contrast to previous studies 
investigating generalized hypervigilance in FM, we used heart beats as stimuli which cannot 
be set at individual threshold levels. Thus, we cannot assure supra-threshold levels of 
stimulation.  
In conclusion, the results suggest that hypervigilance is not a general characteristic of 
FM patients, but one that is rather context dependent or modality-specific.    
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